ArticleMolecules (Basel, Switzerland)2026
Pervaporation Mixed Matrix Membranes from Sodium Alginate/ZnO for Isopropanol Dehydration.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In this work, sodium alginate (NaAlg) membranes were enhanced with synthesized zinc oxide (ZnO) nanoplates to enable efficient pervaporation dehydration of isopropyl alcohol (IPA). A comprehensive suite of characterisation techniques-scanning electron (SEM) and atomic force (AFM) microscopy, Fourier-transform infrared (FTIR) spectroscopy, nuclear magnetic resonance (NMR), X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), thermogravimetric analysis (TGA), contact angle and liquid uptake measurements-along with density functional theory (DFT) calculations, was employed to establish robust structure-property relationships and to elucidate filler-polymer interactions. Membranes with different ZnO contents were prepared, and membranes based on the optimal NaAlg-ZnO(5%) composite were cross-linked with CaCl
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.